5:08 PM
 | 
Jan 18, 2013
 |  BC Extra  |  Financial News

Theravance raises $250M in note deal

Theravance Inc. (NASDAQ:THRX) raised $250 million through the sale of 2.125% convertible subordinated notes due 2023. The unsecured notes initially convert at $27.79,...

Read the full 100 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >